{
    "nctId": "NCT01112189",
    "briefTitle": "Use of Stem Cells in Lymphedema Post Mastectomy",
    "officialTitle": "Postoperative Lymphedema Treatment in Upper Extremities Following Axillary Lymphadenectomy by Transplanting Autologous Endothelial Progenitor Cells (EPC)",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Determine if the stem cells are effective in patients with lymphedema with the decreased of the volume of the affected limb and improvement of the symptomatology.",
    "eligibilityCriteria": "Inclusion criteria:\n\n* Patients with postsurgical lymphedema in upper extremities following axillary lymphadenectomy.\n* Female gender.\n* Age over 18 years.\n* Patients who wish to participate in the study.\n* Informed consent signed.\n\nExclusion criteria:\n\n* Patients with hypercoagulable states.\n* Patients with a history of obstructive vascular disease in the brain, kidneys or heart.\n* Patients with congestive heart failure (ejection fraction less than 30%)\n* Active infectious process, serious, anywhere in the body.\n* Patients over 75 years of age.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}